Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bio-Medical Engineering (HK) Limited
With
The University of Hong Kong
Age
40–70
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Males aged between 40 and 70 years, inclusive, at the time of informed consent
Females aged between 55 and 70 years, inclusive, at the time of informed consent (Rationale: to include only women with non-childbearing potential to avoid completely pregnant trial subjects)
Symptomatic adults indicated for elective colonoscopy, or asymptomatic adults willing to undergo a colonoscopic screening for polyps or colorectal cancer
Adults without prior colonoscopy
Able to provide a written informed consent form approved by an Independent Ethics Committee (IEC)/ Institutional Review Board (IRB), prior to any study-specific procedures
Willing and able to comply with the study procedures
You may not be if
History of colorectal cancer, inflammatory bowel disease, polyposis syndrome, familial polyposis coli, hereditary nonpolyposis colorectal cancer syndrome, active diverticulitis or toxic megacolon
Lower gastrointestinal bleeding within 28 days prior to the colonoscopy day
Known bleeding tendency
Received antiplatelet or anticoagulation therapy within 3 days prior to the colonoscopy day
Known colonic stricture
Known multiple sigmoid colon diverticula
History of any abdominal or pelvis surgical procedures including colonic and rectal surgical resection
Known abdominal wall hernias
History of radiotherapy to the abdomen or pelvis
Known coronary ischemia or cardiovascular stroke within 3 months prior to the colonoscopy day
Contraindication to the proposed anaesthesia
Received any investigational medicine or treatment within 28 days prior to Screening
Any condition, in the opinion of the Investigator, that is unstable and could jeopardize the safety of the subject and their compliance in the study
